Document Detail


Hematin therapy in porphyric attacks.
MedLine Citation:
PMID:  7453089     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report our experience with hematin in the treatment of 57 patients in porphyric attacks. The ratio of acute intermittent porphyria: variegate porphyria: hereditary coproporphyria was 43:11:3. More than 90% of the patients showed not only a decline in their porphyrin precursors, but also a favor able clinical response. Hematin was well tolerated and should be considered the treatment of choice in porphyric relapse.
Authors:
C A Pierach; I Bossenmaier; R Cardinal; M Weimer; C J Watson
Related Documents :
22274169 - A prospective randomized study of intraoperative thoracic epidural analgesia in off-pum...
22285969 - Does additional linear ablation after circumferential pulmonary vein isolation improve ...
22386669 - External validation of the recommendations of the multidisciplinary consensus about inh...
22317929 - Re-operation for failed gastro-esophageal fundoplication. what results to expect?
22510269 - How effective is microwave ablation for atrial fibrillation during concomitant cardiac ...
22705939 - Mindful movement program for older breast cancer survivors: a pilot study.
1348999 - Management of massive upper gastrointestinal haemorrhage from multiple sites of peptic ...
3503019 - Carotid endarterectomy in patients with occlusion of the contralateral carotid artery. ...
21128319 - Redefining the properties of an osmotic agent in an intestinal-specific preservation so...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Klinische Wochenschrift     Volume:  58     ISSN:  0023-2173     ISO Abbreviation:  Klin. Wochenschr.     Publication Date:  1980 Aug 
Date Detail:
Created Date:  1981-03-27     Completed Date:  1981-03-27     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985205R     Medline TA:  Klin Wochenschr     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  829-32     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Heme / analogs & derivatives*
Hemin / therapeutic use*
Humans
Porphyrias / drug therapy*
Chemical
Reg. No./Substance:
14875-96-8/Heme; 16009-13-5/Hemin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adriamycin-cardiomyopathy induced by an increment of (Ca2+) (author's transl)
Next Document:  Lack of involvement of sarcoplasmic reticulum in myopathy of acute phosphorous depletion.